spacer
home > > winter 2018 > smooth sailing
PUBLICATIONS


Smooth Sailing

Clinical trials are performed to accumulate the required information about safety and efficacy of new medicinal products including small and large molecules or medical devices. Before those products hit the healthcare market – if at all – the authorisation procedure passes through numerous steps and stages. In this process, the analysis of clinical samples represents only a minor, but important, portion. Next to safety laboratory testing (which is mandatory in monitoring a new drug), results of lab analyses also provide important evidence on the mode of action of the new medicinal product in vivo.

Pharmacokinetic (PK) tests reveal the buildup of the plasma level of the drug and its successive metabolism and excretion over time. Pharmacodynamic (PD) analyses shed a light on the mode of action of the substance in the human body. More biomarker molecules are being described as an indicator for various physiological conditions. Hence, with each measurement, the researchers gain essential insight into biological processes within the human body.

Subcontracting a Central Lab


For a number of years already, clinical studies have had a tendency to become more complex, consequently leading to challenging analytical demands. Therefore, in multinational trials, many sponsors decide to subcontract one central lab provider instead of many local labs, which results in a broader service portfolio as well as a more efficient sample management and readily comparable lab data.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Sarah Waelde is Manager Business Development at SYNLAB pharma institute – a leading provider of central lab and advanced diagnostic services for the pharma industry, performing general strategic and tactical account-planning next to managing customer relationships. Her expertise in the pharma sector derives from several years of extensive sales. Sarah holds a degree in biology and spent three years as a Postdoctoral Researcher at the YALE School of Medicine, US, investigating the activation of mitotic entry in fission yeast.

Dr Holger Schoeneborn
has more than 15 years of experience in the pharma industry. After 11 years in project management and involvement in more than 100 clinical trials, he is now heading the sample management department and scientific support at SYNLAB pharma institute in Munich. Holger holds a PhD degree in biology from the Technical University Munich, Germany.

spacer
Dr Sarah Waelde
spacer
spacer
spacer
Dr Holger Schoeneborn
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ERT Virtual Visit Capabilities Keep Clinical Trials on Track during COVID-19

ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced a Virtual Visit solution that enables the continuation of clinical trials during and after current global stay-at-home mandates. As a result of COVID-19, many clinical trials have been delayed as healthcare providers focus their efforts on patients who require urgent care, which limits clinical trial patients’ access to investigative sites for routine visits.
More info >>

White Papers

Clinical Research in Spain

BioClever

This whitepaper is on clinical research in Spain, giving a general outline of the main characteristics of research in this country and an overview of the applicable regulations, along with the reasons why Spain is a good place to do research.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement